Use of cookies

Lund University uses cookies to ensure that the website functions properly and to improve your experience.

Read more in our cookie policy

Search results

Filter

Reset filter

Filetype

Your search for "*" yielded 543353 hits

Antibiotic prescription practices, consumption and bacterial resistance in a cross section of Swedish intensive care units

Background: The purpose of this work was to study usage of antibiotics, its possible determinants, and patterns of bacterial resistance in Swedish intensive care units (ICUs). Methods: Prospectively collected data on species and antibiotic resistance of clinical isolates and antibiotic consumption specific to each ICU in 1999 were analyzed together with answers to a questionnaire. Antibiotic usage

High antibiotic susceptibility among bacterial pathogens in Swedish ICUs

Local infection control measures, antibiotic consumption and patient demographics from 1999-2000 together with bacteriological analyses were investigated in 29 ICUs participating in the ICU-STRAMA programme. The median antibiotic consumption per ICU was 1147 (range 605-2143) daily doses per 1000 occupied bed d (DDD1000). Antibiotics to which >90% of isolates of an organism were susceptible were de

Så spred sig tobaken över världen.

Tobaksrökning är som tur är på nedåtgående i de flesta länder. Ändå är tobaksodlingen fortfarande en stor industri och många hoppas på att hitta nya användningsområden för denna giftiga växt. Lars Olof Björn och Ingvar Kärnefelt berättar tobakens historia ur ett både botaniskt och mänskligt perspektiv.

Efficacy and safety of tailored and dose-dense adjuvant chemotherapy and trastuzumab for resected HER2-positive breast cancer : Results from the phase 3 PANTHER trial

Background: Dose-dense (DD) adjuvant chemotherapy improves outcomes in early breast cancer (BC). However, there are no phase 3 randomized data to inform on its combination with trastuzumab for patients with human epidermal growth factor receptor 2 (HER2)–positive disease. Methods: This was a protocol-predefined secondary analysis of the randomized phase 3 Pan-European Tailored Chemotherapy (PANTHE

Turnover of 125I-labelled tissue kallikrein following intraduodenal or intravenous administration

UNLABELLED: Tissue kallikrein is released in the body both physiologically and in many inflammatory disorders. Little is, however, known about the turnover of released tissue kallikrein in humans. Approximately 1 mg of tissue kallikrein (mol wt 43,000 Da) was purified from 85 L human urine by: (1) ultracentrifugation, (2) filtration through an aprotinin-coupled Sepharose 4B column, followed by (3)

Prediction of the radionuclide inventory in the European Spallation Source target using FLUKA

The FLUKA code was applied to a simplified model of the tungsten target of the European Spallation Source (ESS) and shown to be suitable for modelling the radionuclide inventory of the ESS target. Two groups of radionuclides were selected based on dose factors and total predicted activities, one immediately after 5 years (designed lifetime of the target) of operation, and the other 10 years after